Thyrocare - Stimulating Model To Restore Profitability: ICICI Securities

Leveraging its dominance in the B2B diagnostic business in India, Thyrocare’s new management has charted a roadmap to boost strong 15–17% growth in its base business of pathology

<div class="paragraphs"><p>Blood samples arrangement in a lab. (Source: freepik)</p></div>
Blood samples arrangement in a lab. (Source: freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More